Immunic, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $97.6M | $102.2M |
| FY2015 | — | $82.3M | $83.4M |
| FY2016 | — | $58.4M | $60.0M |
| FY2017 | — | $-13.3M | $56.9M |
| FY2018 | — | $-25.7M | $13.1M |
| FY2019 | — | $58.4M | $29.4M |
| FY2020 | — | $158.8M | $127.5M |
| FY2021 | — | $127.1M | $86.9M |
| FY2022 | — | $113.7M | $106.7M |
| FY2023 | — | $28.9M | $46.7M |